← Browse by Condition
Medical Condition

antibody mediated rejection

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT04561986 Phase 3
Recruiting

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Enrollment
50 pts
Location
Spain, Sweden
Sponsor
Vastra Gotaland Region
View Trial →